SlideShare a Scribd company logo
CATEGORY:
BIOENGINEERING AND
BIOTECHNOLOGY
PREMIO 2014-2015 organizzato da
Associazione LIFEBILITY
per la diffusione dell’ETICA sociale LIONS presso i giovani
e per favorire l’ingresso nel mondo del lavoro
BIOENGINEERING AND BIOTECHNOLOGY
PROJECT N°9
Plant viruses and new care
Sara CIONCI - Salerno
PREMIO 2014-2015 organizzato da
Associazione LIFEBILITY
per la diffusione dell’ETICA sociale LIONS presso i giovani
e per favorire l’ingresso nel mondo del lavoro
“Plant viruses and new care ”
A revolution in the production and administration
of vaccines
EDIBLE VACCINES
Plant viruses can be genetically modified to
produce vaccines into vegetables and fruits.
activate both mucosal and systemic
immunity
009 – Plant viruses and new care / Sara Cionci
Purpose
To create edible influenza vaccines
in the form of plant extract
for oral administration
Influenza virus is a
widespread pathogen and
has an high infection rate
009 – Plant viruses and new care / Sara Cionci
Benefits
HEALTH: avoidance of potentially toxic adjuvants
used in traditional vaccines, like Aluminum
(neurotoxicity and autism)
ENVIRONMENT: cleaner production chains
No need of syringes and needles: this decreases
chances of infection and eliminates the need for
trained medical personnel.
High impact especially in developing countries.
Potential issues related to GMO are avoided
009 – Plant viruses and new care / Sara Cioncic
STEP 1 :
Research
• Selection of the plant virus we will use as
a vector of an Influenza virus portion
• Engineered vector will infect plants we
choose for the project; virus stability and
immunogenicity will be tested
• Quantitative evaluations
Fragment of
Influenza virus DNA
Into plant virus
DNA
Plant extract
we can use
as vaccine
Vector
introduced into
plant cells
009 – Plant viruses and new care / Sara Cioncic
STEP 2 :
Production
and
Marketing
• Realization of the greenhouses for the
growth of plants in optimal conditions
• Packaging vegetable extracts in
single-dose vials
• Promotion of the new vaccine in the
scientific community and the market
009 – Plant viruses and new care / Sara Cioncic
Flu shot
more than 10 million people are vaccinated
against Influenza virus every year in Italy
Pharmacies
- age> 65 years
-chronic diseases
ASL
Influenza virus kills 8500 people in Italy every year,
half a million all over the world
009 – Plant viruses and new care / Sara Cioncic
“Plant viruses and new care”
Plant virus we choose
can be engineered every year
in the same way to create the
new Influenza vaccine
In the future we can use the same plant virus
to produce many other medical products like
anticancer drugs, food supplements, etc.
009 – Plant viruses and new care / Sara Cioncic
“Feeding the planet”
009 – Plant viruses and new care / Sara Cioncic

More Related Content

Similar to 009 eng

Rappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013ridRappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013rid
Scienzainrete
 
Livestock vaccines: Development and market access
Livestock vaccines: Development and market accessLivestock vaccines: Development and market access
Livestock vaccines: Development and market access
ExternalEvents
 
Edible vaccine
Edible vaccineEdible vaccine
Edible vaccine
EricaAgarwal
 
immunization IAP 2014 recommendation
immunization IAP 2014 recommendationimmunization IAP 2014 recommendation
immunization IAP 2014 recommendation
Liza Bulsara
 
VACCINES AND ITS PRODUCTION
VACCINES AND ITS PRODUCTIONVACCINES AND ITS PRODUCTION
VACCINES AND ITS PRODUCTION
RathikaRagupathi
 
Newer vaccine
Newer vaccineNewer vaccine
Newer vaccine
Dr Bushra Jabeen
 
Vaccine
Vaccine Vaccine
Vaccine
Syazana Husin
 
India Contribute to world.pptx
India Contribute to world.pptxIndia Contribute to world.pptx
India Contribute to world.pptx
GAUSWAMI RAVINDRAGIRI
 
Current and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRICurrent and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRI
ILRI
 
Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...
Graham Atherton
 
Ann ginsberg
Ann ginsbergAnn ginsberg
Ann ginsberg
Rosella Anstine
 
Inovio sep13pres
Inovio sep13presInovio sep13pres
Inovio sep13pres
Company Spotlight
 
Inovio sep13 presentation
Inovio sep13 presentationInovio sep13 presentation
Inovio sep13 presentation
Company Spotlight
 
Current and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRICurrent and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRI
ILRI
 
Covid 19 vaccine
Covid 19 vaccineCovid 19 vaccine
Covid 19 vaccine
HemeshaMurthyMurthy
 
Plant derived-vaccines
Plant derived-vaccinesPlant derived-vaccines
Plant derived-vaccines
primary information services
 
FOOD AS VACCINE
FOOD AS VACCINE FOOD AS VACCINE
FOOD AS VACCINE
konatham teja kumar reddy
 
SUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine actionSUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine action
Gagan Sharma
 
Development of Covid-19 Vaccine.pptx.pptx
Development of  Covid-19  Vaccine.pptx.pptxDevelopment of  Covid-19  Vaccine.pptx.pptx
Development of Covid-19 Vaccine.pptx.pptx
Aquib Reza
 
Edible vaccine
Edible vaccineEdible vaccine
Edible vaccine
KAUSHAL SAHU
 

Similar to 009 eng (20)

Rappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013ridRappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013rid
 
Livestock vaccines: Development and market access
Livestock vaccines: Development and market accessLivestock vaccines: Development and market access
Livestock vaccines: Development and market access
 
Edible vaccine
Edible vaccineEdible vaccine
Edible vaccine
 
immunization IAP 2014 recommendation
immunization IAP 2014 recommendationimmunization IAP 2014 recommendation
immunization IAP 2014 recommendation
 
VACCINES AND ITS PRODUCTION
VACCINES AND ITS PRODUCTIONVACCINES AND ITS PRODUCTION
VACCINES AND ITS PRODUCTION
 
Newer vaccine
Newer vaccineNewer vaccine
Newer vaccine
 
Vaccine
Vaccine Vaccine
Vaccine
 
India Contribute to world.pptx
India Contribute to world.pptxIndia Contribute to world.pptx
India Contribute to world.pptx
 
Current and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRICurrent and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRI
 
Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...
 
Ann ginsberg
Ann ginsbergAnn ginsberg
Ann ginsberg
 
Inovio sep13pres
Inovio sep13presInovio sep13pres
Inovio sep13pres
 
Inovio sep13 presentation
Inovio sep13 presentationInovio sep13 presentation
Inovio sep13 presentation
 
Current and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRICurrent and future animal vaccine research activities at ILRI
Current and future animal vaccine research activities at ILRI
 
Covid 19 vaccine
Covid 19 vaccineCovid 19 vaccine
Covid 19 vaccine
 
Plant derived-vaccines
Plant derived-vaccinesPlant derived-vaccines
Plant derived-vaccines
 
FOOD AS VACCINE
FOOD AS VACCINE FOOD AS VACCINE
FOOD AS VACCINE
 
SUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine actionSUBTOPIC: COVID-19 vaccine action
SUBTOPIC: COVID-19 vaccine action
 
Development of Covid-19 Vaccine.pptx.pptx
Development of  Covid-19  Vaccine.pptx.pptxDevelopment of  Covid-19  Vaccine.pptx.pptx
Development of Covid-19 Vaccine.pptx.pptx
 
Edible vaccine
Edible vaccineEdible vaccine
Edible vaccine
 

More from Associazione Lifebility

073 eng
073 eng073 eng
065 eng
065 eng065 eng
062 eng
062 eng062 eng
055 eng
055 eng055 eng
044 eng
044 eng044 eng
043 eng
043 eng043 eng
040 eng
040 eng040 eng
035 eng
035 eng035 eng
033 eng
033 eng033 eng
030 eng
030 eng030 eng
027 eng
027 eng027 eng

More from Associazione Lifebility (20)

077 eng
077 eng077 eng
077 eng
 
073 eng
073 eng073 eng
073 eng
 
072 eng
072 eng072 eng
072 eng
 
071 eng
071 eng071 eng
071 eng
 
068 eng
068 eng068 eng
068 eng
 
065 eng
065 eng065 eng
065 eng
 
062 eng
062 eng062 eng
062 eng
 
059 eng
059 eng059 eng
059 eng
 
055 eng
055 eng055 eng
055 eng
 
049 eng
049 eng049 eng
049 eng
 
044 eng
044 eng044 eng
044 eng
 
043 eng
043 eng043 eng
043 eng
 
040 eng
040 eng040 eng
040 eng
 
039 eng
039 eng039 eng
039 eng
 
038 eng
038 eng038 eng
038 eng
 
035 eng
035 eng035 eng
035 eng
 
033 eng
033 eng033 eng
033 eng
 
032 eng
032 eng032 eng
032 eng
 
030 eng
030 eng030 eng
030 eng
 
027 eng
027 eng027 eng
027 eng
 

009 eng

  • 1.
  • 2. CATEGORY: BIOENGINEERING AND BIOTECHNOLOGY PREMIO 2014-2015 organizzato da Associazione LIFEBILITY per la diffusione dell’ETICA sociale LIONS presso i giovani e per favorire l’ingresso nel mondo del lavoro
  • 3. BIOENGINEERING AND BIOTECHNOLOGY PROJECT N°9 Plant viruses and new care Sara CIONCI - Salerno PREMIO 2014-2015 organizzato da Associazione LIFEBILITY per la diffusione dell’ETICA sociale LIONS presso i giovani e per favorire l’ingresso nel mondo del lavoro
  • 4. “Plant viruses and new care ” A revolution in the production and administration of vaccines EDIBLE VACCINES Plant viruses can be genetically modified to produce vaccines into vegetables and fruits. activate both mucosal and systemic immunity 009 – Plant viruses and new care / Sara Cionci
  • 5. Purpose To create edible influenza vaccines in the form of plant extract for oral administration Influenza virus is a widespread pathogen and has an high infection rate 009 – Plant viruses and new care / Sara Cionci
  • 6. Benefits HEALTH: avoidance of potentially toxic adjuvants used in traditional vaccines, like Aluminum (neurotoxicity and autism) ENVIRONMENT: cleaner production chains No need of syringes and needles: this decreases chances of infection and eliminates the need for trained medical personnel. High impact especially in developing countries. Potential issues related to GMO are avoided 009 – Plant viruses and new care / Sara Cioncic
  • 7. STEP 1 : Research • Selection of the plant virus we will use as a vector of an Influenza virus portion • Engineered vector will infect plants we choose for the project; virus stability and immunogenicity will be tested • Quantitative evaluations Fragment of Influenza virus DNA Into plant virus DNA Plant extract we can use as vaccine Vector introduced into plant cells 009 – Plant viruses and new care / Sara Cioncic
  • 8. STEP 2 : Production and Marketing • Realization of the greenhouses for the growth of plants in optimal conditions • Packaging vegetable extracts in single-dose vials • Promotion of the new vaccine in the scientific community and the market 009 – Plant viruses and new care / Sara Cioncic
  • 9. Flu shot more than 10 million people are vaccinated against Influenza virus every year in Italy Pharmacies - age> 65 years -chronic diseases ASL Influenza virus kills 8500 people in Italy every year, half a million all over the world 009 – Plant viruses and new care / Sara Cioncic
  • 10. “Plant viruses and new care” Plant virus we choose can be engineered every year in the same way to create the new Influenza vaccine In the future we can use the same plant virus to produce many other medical products like anticancer drugs, food supplements, etc. 009 – Plant viruses and new care / Sara Cioncic
  • 11. “Feeding the planet” 009 – Plant viruses and new care / Sara Cioncic

Editor's Notes

  1. Il progetto fitovirus e nuove cure si propone di rivoluzionare le modalità di produzione e somministrazione dei vaccini creando vaccini EDIBILI, sfruttando i fitovirus, ovvero virus vegetali, come vettori di porzioni esogene all’interno di frutta e verdura, inducendo immunità, proprio come fanno i vaccini, ma in seguito all’ingestione.
  2. In particolare, l’obiettivo del progetto è quello di realizzare vaccini antinfluenzali sottoforma di estratti vegetali da somministrare per via orale mediante fiale monodose
  3. Con una serie di importanti vantaggi: per la salute, in quanto si eviterebbe di usare adiuvanti potenzialmente tossici, presenti oggi nella quasi totalità dei vaccini, come ad esempio metalli, tra cui l’alluminio, neurotossici e per questo recentemente identificati come la potenziale causa dell’aumento di danni cerebrali, in particolare l’autismo (ad oggi non esistono dati certi a riguardo ma è aumentata la sensibilità al problema, soprattutto da parte dei genitori che devono sottoporre i propri figli ai vaccini); i vaccini edibili permetterebbero di sostituire aghi e siringhe con la più semplice somministrazione orale, che non richiede personale specializzato, utile soprattutto nei paesi meno sviluppati; i vantaggi riguardano anche l’ambiente perché la filiera produttiva sarebbe meno inquinante rispetto a quella attuale; in più in questo modo si bypassano le problematiche legate agli OGM (in quanto non viene ingegnerizzato un organismo vivente bensì un virus, che non lo è per definizione )
  4. Il progetto prevede una prima fase di RICERCA, nella quale individuare e poi ingegnerizzare il fitovirus avente le migliori caratteristiche come vettore di una porzione esogena derivante dal virus influenzale contro cui vogliamo ottenere il vaccino; in seguito, infettate le piante target opportunamente scelte, vanno testate la stabilità e l’immunogenicità e valutati gli aspetti quantitativi.
  5. La seconda fase, quella di PRODUZIONE E PROMOZIONE, prevede la realizzazione di serre per la crescita in condizioni ottimali delle piante prescelte, il confezionamento degli estratti vegetali in fiale monodose e la promozione del nuovo vaccino all’interno della comunità scientifica e sul mercato.
  6. Il vaccino antinfluenzale viene fornito gratuitamente dalle ASL a determinate categorie di pazienti mentre nelle farmacie lo può acquistare chiunque decida di vaccinarsi. Circa 8500 sono le vittime del virus in Italia ogni anno, mezzo milione in tutto il pianeta. In Italia sono più di 10 milioni le persone che ogni anno si vaccinano contro l’influenza
  7. Come sappiamo il vaccino antinfluenzale varia di anno in anno a causa dell’alta variabilità del virus: questa nuova modalità di produzione non solo può essere impiegata per realizzare ogni anno il nuovo vaccino antinfluenzale, ma è possibile in futuro utilizzarlo analogamente per realizzare altri vaccini e prodotti di interesse medico come farmaci, antitumorali, etc.